  The planning and conduct of animal experiments in the European Union is
subject to strict legal conditions. Still, many preclinical animal experiments
are only poorly designed. As a consequence, discoveries that are made in one
animal experiment, cannot be reproduced in another animal experiment or
discoveries in translational animal research fail to be translated to humans.
When designing new experiments in a classical frequentist framework, the sample
size for the new experiment is chosen with the goal to achieve at least a
certain statistical power, given a statistical test for a null hypothesis, a
significance threshold and a minimally relevant effect size. In a Bayesian
framework, inference is made by a combination of both the information from
newly observed data and also by a prior distribution, that represents a priori
information on the parameters. In translational animal experiments, a priori
information is present in previously conducted experiments to the same outcome
in similar animals. The prior information can be incorporated in a systematic
way in the design and analysis of a new animal experiment by summarizing the
historical data in a (Bayesian) meta-analysis model and using the meta-analysis
model to make predictions for the data in the new experiment. This is called
meta-analytic predictive (MAP) approach. In this work, concepts of how to
design translational animal experiments by MAP approaches are introduced and
compared to classical frequentist power-oriented sample size planning. Current
chances and challenges, that exist in the practical application of these
approaches in translational animal research, are discussed. Special emphasis is
put on the construction of prior distributions and sample size calculation by
design analysis. The considerations are motivated by a real world translational
research example.
